首页 | 本学科首页   官方微博 | 高级检索  
     

3项指标联合检测在肝细胞肝癌中的诊断价值
引用本文:李淑群,陈谦,喻亚群,梅铭惠,莫庆荣,覃里灵,廖维甲. 3项指标联合检测在肝细胞肝癌中的诊断价值[J]. 检验医学与临床, 2010, 7(21): 2305-2306. DOI: 10.3969/j.issn.1672-9455.2010.21.001
作者姓名:李淑群  陈谦  喻亚群  梅铭惠  莫庆荣  覃里灵  廖维甲
作者单位:桂林医学院附属医院肝胆外科,广西桂林,541001
基金项目:广西卫生厅重点科研课题资助 
摘    要:目的探讨血清甲胎蛋白、可溶性细胞间黏附分子-1及高尔基体膜蛋白-73在肝细胞肝癌(HCC)中的诊断价值。方法住院患者221例中原发性肝癌44例,其他肝恶性肿瘤14例,肝良性疾病74例,非肝脏疾病49例及健康献血者40例,用酶联免疫吸附试验(ELISA)测定各组血清中高尔基体膜蛋白-73及可溶性细胞间黏附分子-1,用荧光ELISA测定各组血清中甲胎蛋白含量。结果甲胎蛋白、可溶性细胞间黏附分子-1及高尔基体膜蛋白-73联合检测可使原发性肝癌的检出敏感性和特异性分别达86%和93%,高于其中任一单项检测,可明显提高HCC患者的阳性率。结论 3项联合检测对诊断HCC具有重要临床价值。

关 键 词:肝细胞肝癌  甲胎蛋白  可溶性细胞间黏附分子-1  高尔基体膜蛋白-73

Clinical value of the combined detection of three markers in diagnosing primary hepatic carcinoma
LI Shu-qun,CHEN Qian,YU Ya-qun,MEI Ming-hui,MO Qing-rong,QIN Li-lin,LIAO Wei-jia. Clinical value of the combined detection of three markers in diagnosing primary hepatic carcinoma[J]. Laboratory Medicine and Clinic, 2010, 7(21): 2305-2306. DOI: 10.3969/j.issn.1672-9455.2010.21.001
Authors:LI Shu-qun  CHEN Qian  YU Ya-qun  MEI Ming-hui  MO Qing-rong  QIN Li-lin  LIAO Wei-jia
Affiliation:LI Shu-qun,CHEN Qian,YU Ya-qun,MEI Ming-hui,MO Qing-rong,QIN Li-lin,LIAO Wei-jia.Surgery Department of Gall and Liver,the Affiliated Hospital of Guilin Medical College,Guangxi 200883,China
Abstract:Objective To study the clinical significance of serum alpfa-fetoprotein(AFP) soluble intercellular adhesion moleculer-1(sICAM-1) and Golgiprotein-73(GP73) in diagnosing hepatic cellular carcinoma.Methods 221 cases of patients including 44cases of hepatic cellular carcinoma,14 cases of other hepatic carcinoma,74 cases of hepatic benign diseases,49 cases of unhepatic diseases and 40 cases of nomal controls were determined,and 73 were determined with double antibody enzyme linked immunosorbent assay alpha-feto...
Keywords:hepatic cellular carcinoma  alpha-fetoprotein  soluble intercellular adhesion molecule-1  GP 73  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号